CXCR2 and neoplasm: A combined blockage of CCR2 and CXCR2 in a murine PDAC model prevented both CCR2+ macrophages and CXCR2+ neutrophils from entering the tumor, which led to an improved anti-tumor immunity and response to chemotherapy [113].